Surgery Partners, Inc. (NASDAQ:SGRY) Stake Trimmed by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC cut its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 8.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 230,000 shares of the company’s stock after selling 20,000 shares during the quarter. Surgery Partners accounts for 3.1% of Sivik Global Healthcare LLC’s portfolio, making the stock its 12th largest position. Sivik Global Healthcare LLC owned about 0.18% of Surgery Partners worth $7,415,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Quarry LP boosted its position in shares of Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after buying an additional 1,760 shares during the period. KBC Group NV grew its stake in Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after acquiring an additional 576 shares in the last quarter. DekaBank Deutsche Girozentrale increased its holdings in shares of Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after purchasing an additional 1,375 shares during the period. EntryPoint Capital LLC lifted its position in shares of Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after purchasing an additional 4,607 shares in the last quarter. Finally, Creative Planning acquired a new stake in shares of Surgery Partners during the third quarter worth approximately $258,000.

Surgery Partners Stock Up 0.6 %

Shares of SGRY stock opened at $25.66 on Thursday. Surgery Partners, Inc. has a 12 month low of $22.25 and a 12 month high of $36.92. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96. The firm has a market cap of $3.26 billion, a PE ratio of -53.14, a price-to-earnings-growth ratio of 2.34 and a beta of 2.76. The stock has a 50 day moving average of $30.88 and a 200-day moving average of $28.47.

Analysts Set New Price Targets

SGRY has been the topic of several research reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $49.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. Citigroup cut their price objective on Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research note on Friday, October 4th. KeyCorp started coverage on Surgery Partners in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Finally, UBS Group initiated coverage on Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 price target for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Surgery Partners has a consensus rating of “Moderate Buy” and a consensus price target of $40.00.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.